News

Increased daily rate forSME owners and Natural persons persons beneficiaries

Published on | 1 year ago

Programmes Horizon Europe HorizonEU L+F

The personnel cost of SME owners and natural person beneficiaries has to be declared by using the unit cost (daily rate) fixed by the authorising decision C(2020)71155 and set out in Annex 2a, as explained in the Annotated Model Grant Agreement p. 64.

This Annex 2a has been updated on 01/08/202: for calls with opening date as from 30 July 2024 the daily rate has been changed to EUR 8 745,40 / 18 days = 485,85 multiplied by the country-specific correction coefficien of the country where the beneficiary is etablished;  if Belgium, then this coëfficient is 1.

For calls with opening date before 30 July 2024, this daily rate remains EUR 5 080 / 18 days = 282,22 multiplied by the country-specific correction coefficient of the country where the beneficiary is etablished; if Belgium, then this coëfficient is 1.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1742 articles available search in articles 

Testimonial

image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.